Peregrine Pharmaceuticals

Why Peregrine Earnings Are Stuck in the Red
Motley Fool
Tue, 07/9/13 - 11:45 am
Peregrine Pharmaceuticals
earnings
Peregrine Pharmaceuticals drops sharply after halting study of potential lung cancer treatment
Yahoo/AP
Thu, 06/27/13 - 11:14 am
Peregrine Pharmaceuticals
lung cancer
bavituximab
This Week in Biotech
Motley Fool
Sun, 05/26/13 - 11:18 am
AcelRx
Peregrine Pharmaceuticals
Merck
XenoPort
Aveo Pharmaceuticals
Astellas
Encouraging News for Peregrine Pharma
Yahoo/Zacks
Sat, 05/25/13 - 11:34 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
lung cancer
Peregrine Pharma agrees with FDA on lung cancer trial design
Reuters
Mon, 05/20/13 - 11:42 am
FDA
Peregrine Pharmaceuticals
lung cancer
bavituximab
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Sat, 05/4/13 - 10:32 am
Vertex Pharmaceuticals
Pharmacyclics
Novartis
Celsion
Peregrine Pharmaceuticals
Prana
Navidea Biopharmaceuticals
Cardinal Health
ONYX Pharmaceuticals
Bayer
Sarepta
Hyperion Therapeutics
Amarin
Medivation
Astellas
JNJ
Trius
Sangamo BioSciences
Peregrine Pharmaceuticals Earnings: An Early Look
Motley Fool
Sun, 03/10/13 - 11:55 am
Peregrine Pharmaceuticals
earnings
Peregrine's Epic Failure (Maybe)
Motley Fool
Fri, 02/15/13 - 11:42 am
Peregrine Pharmaceuticals
pancreatic cancer
bavituximab
Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug
TheStreet.com
Wed, 02/13/13 - 11:00 am
Peregrine Pharmaceuticals
bavituximab
pancreatic cancer
3 Biotechs Burning Through Cash
Motley Fool
Sat, 02/2/13 - 11:39 am
Peregrine Pharmaceuticals
Ziopharm
Keryx
4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wed, 01/9/13 - 10:06 am
Vivus
Peregrine Pharmaceuticals
JNJ
Cellceutix
Peregrine Recovers As Phase II Trial Is Salvaged
Seeking Alpha
Wed, 01/9/13 - 09:31 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
Peregrine Pharmaceuticals Beats Earnings Estimates
Seeking Alpha
Tue, 12/11/12 - 11:32 am
earnings
Peregrine Pharmaceuticals
Is the Risk Worth the Reward for Biotech’s Most Volatile?
Motley Fool
Sun, 12/2/12 - 12:04 pm
Acura Pharmaceuticals
Peregrine Pharmaceuticals
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Peregrine Pharmaceuticals, Inc. To Contact The Firm
Yahoo/PR Newswire
Sat, 11/17/12 - 01:45 pm
Peregrine Pharmaceuticals
lawsuits
4 Biotechs That Just Got Mauled By Bears
Seeking Alpha
Wed, 10/10/12 - 12:05 pm
Neuralstem
Peregrine Pharmaceuticals
Celsion
Athersys
Lessons From Biotech's Best Third Quarter Stocks
TheStreet.com
Tue, 10/2/12 - 11:59 am
Celsion
XenoPort
Peregrine Pharmaceuticals
Sunesis
Opexa
StemCells
Catalyst Pharmaceutical Partners
Hemispherx
Sarepta
Savient
Assessing Peregrine And Seeking Upside In The Space
Seeking Alpha
Mon, 10/1/12 - 12:28 pm
Peregrine Pharmaceuticals
Galena Biopharma
Roche
Sunesis
Peregrine: Investors are Shocked Over This Murky Future
Wall Street Cheat Street
Sun, 09/30/12 - 10:35 am
Peregrine Pharmaceuticals
CEO Gaffe of the Week: Peregrine Pharmaceuticals
Motley Fool
Sat, 09/29/12 - 12:23 pm
Peregrine Pharmaceuticals

Pages